ab1183 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab1183 は 10 報の論文で使用されています。

  • Acuna-Hidalgo R  et al. Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies. PLoS Genet 13:e1006683 (2017). PubMed: 28346496
  • Mody HR  et al. SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. Oncotarget 8:67966-67979 (2017). PubMed: 28978088
  • Saavedra F  et al. PP32 and SET/TAF-Iß proteins regulate the acetylation of newly synthesized histone H4. Nucleic Acids Res 45:11700-11710 (2017). PubMed: 28977641
  • Wang S  et al. Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia. Oncotarget 6:12128-40 (2015). PubMed: 25900240
  • Yabe R  et al. Characterization of SET/I2PP2A isoforms in dogs. J Vet Med Sci 76:1235-40 (2014). WB . PubMed: 24897959
  • Mansouri S  et al. A role for the nucleosome assembly proteins TAF-Iß and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation. PLoS One 8:e63802 (2013). WB ; Human . PubMed: 23691099
  • Quentmeier H  et al. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. J Hematol Oncol 2:3 (2009). WB ; Human . PubMed: 19166587
  • Vera J  et al. Proteomic analysis of SET-binding proteins. Proteomics 7:578-87 (2007). WB . PubMed: 17309103
  • Carujo S  et al. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene 25:4033-42 (2006). Rabbit . PubMed: 16474839
  • Vera J  et al. Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor. Oncogene 25:260-70 (2006). PubMed: 16170352

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録